Applying artificial intelligence for cancer immunotherapy
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Artificial intelligence (AI) is a general term that refers to the use of a machine to imitate intelligent behavior for performing complex tasks with minimal human intervention, such as machine learning; this technology is revolutionizing and reshaping medicine. AI has considerable potential to perfect health-care systems in areas such as diagnostics, risk analysis, health information administration, lifestyle supervision, and virtual health assistance. In terms of immunotherapy, AI has been applied to the prediction of immunotherapy responses based on immune signatures, medical imaging and histological analysis. These features could also be highly useful in the management of cancer immunotherapy given their ever-increasing performance in improving diagnostic accuracy, optimizing treatment planning, predicting outcomes of care and reducing human resource costs. In this review, we present the details of AI and the current progression and state of the art in employing AI for cancer immunotherapy. Furthermore, we discuss the challenges, opportunities and corresponding strategies in applying the technology for widespread clinical deployment. Finally, we summarize the impact of AI on cancer immunotherapy and provide our perspectives about underlying applications of AI in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
A survey on deep learning in medical image analysis
Litjens, G., Kooi, T., Bejnordi, B. E., Setio, A. A. A., Ciompi, F., Ghafoorian, M., van der Laak, J. A. W. M., van Ginneken, B., & Sánchez, C. I. (2017) · Medical Image Analysis · doi:10.1016/j.media.2017.07.005 · Cited by 15,332
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450 · cited 1×
“Problems with extensively used software might quickly impact many patients 138 .”
MethodOverall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C. L., Lao, C. D., Wagstaff, J., Schadendorf, D., Ferrucci, P. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709684 · Cited by 5,357
A guide to deep learning in healthcare
Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., Cui, C., Corrado, G., Thrun, S., & Dean, J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0316-z · Cited by 5,312 · cited 1×
“Third, we should understand the perspectives of the patient, practitioner and public in regards to the acceptability, benefits and risks of AI approaches in successful immunotherapy, as well as in establishing institutional and social mechanisms deserving acceptance and trust 141,142 .”
BackgroundA New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981 · cited 1×
“More-over, many studies have confirmed that higher T cell infiltration levels and increased tumor-infiltrating lymphocyte numbers are related to better immune-checkpoint blockades 77 .”
BackgroundRajkomar, A., Dean, J., & Kohane, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1814259 · Cited by 4,579 · cited 3×
“…of data and related outcomes, AI approaches enable computers to become progressively better in conducting a specific task and then generating decision support systems, revealing promise in their accuracy of distinguishing diverse immunohistochemical scores, cancer subtypes, and biomarkers 7 .”
BackgroundMethodInfluentialDeo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.115.001593 · Cited by 3,466
Tumor mutational burden and response rate to PD-1 inhibition
Yarchoan, M., Hopkins, A., & Jaffee, E. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1713444 · Cited by 3,230 · cited 1×
“Moreover, ML models using gene mutation features might serve as biomarkers for immunotherapy prognosis and guidance 75,82,83 .”
MethodGenomic correlates of response to CTLA-4 blockade in metastatic melanoma
Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839 · cited 1×
“In addition, certain genomic or genetic features, such as PD-L1 expression, deficient DNA mismatch repair, neoantigen load and tumor mutation burden, are also relevant to immunotherapeutic responses that could be further researched and combined in an AI application 49 e 51 .”
BackgroundArtificial intelligence in healthcare
Yu, K.-H., Beam, A. L., & Kohane, I. S. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0305-z · Cited by 2,817
Wang, D. Y., Salem, J.-E., Cohen, J. V., Chandra, S., Menzer, C., Ye, F., Zhao, S., Das, S., Beckermann, K. E., Ha, L., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.3923 · Cited by 2,674
Camerer, C. F., Dreber, A., Holzmeister, F., Ho, T.-H., Huber, J., Johannesson, M., Kirchler, M., Nave, G., Nosek, B. A., Pfeiffer, T., et al. (2018) · Nature Human Behaviour · doi:10.1038/s41562-018-0399-z · Cited by 1,521
Kather, J. N., Pearson, A. T., Halama, N., Jäger, D., Krause, J., Loosen, S. H., Marx, A., Boor, P., Tacke, F., Neumann, U. P., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0462-y · Cited by 1,458 · cited 1×
“Notably, Kather et al. 26 confirmed that deep residual learning could predict MMR status directly from H&E-stained histology slides in gastrointestinal cancer patients.”
BackgroundMechanisms of resistance to immune checkpoint inhibitors
Jenkins, R. W., Barbie, D. A., & Flaherty, K. T. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.434 · Cited by 1,383 · cited 1×
“Other mechanisms include insufficient generation and effector function of anti-tumor T-cells and impaired formation of T-cell memory 98 .”
BackgroundSun, R., Limkin, E. J., Vakalopoulou, M., Dercle, L., Champiat, S., Han, S. R., Verlingue, L., Brandao, D., Lancia, A., Ammari, S., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30413-3 · Cited by 1,236 · cited 2×
“Through combining RNA-seq genomic data from tumor biopsies and contrast-enhanced CT images, this radiomics approach provided a promising method to evaluate the tumor-infiltrating CD8 signature and infer clinical outcomes for cancer patients 21 .”
BackgroundMethodDigital pathology and artificial intelligence
Niazi, M. K. K., Parwani, A. V., & Gurcan, M. N. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30154-8 · Cited by 1,232 · cited 1×
“For example, integration of AI into pathology will generate an advanced diagnostics and improved workflow, empowering clinicians to review and share images quickly, and employ computational algorithms to assess valuable insights for acquiring a more informed and detailed cancer diagnosis 103,104 .”
BackgroundSirinukunwattana, K., Raza, S. E. A., Tsang, Y.-W., Snead, D. R. J., Cree, I. A., & Rajpoot, N. M. (2016) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2016.2525803 · Cited by 1,224 · cited 2×
“In a seminal paper in 2016, Sirinukunwattana et al. 72 demonstrated that a spatially constrained convolutional neural network combined with neighboring ensemble predictor accurately accomplished the detection and classification of the nucleus in routine colon cancer histology images, which benefited…”
BackgroundNagendran, M., Chen, Y., Lovejoy, C. A., Gordon, A. C., Komorowski, M., Harvey, H., Topol, E. J., Ioannidis, J. P. A., Collins, G. S., & Maruthappu, M. (2020) · BMJ · doi:10.1136/bmj.m689 · Cited by 1,152 · cited 2×
“Moreover, most non-randomized studies are not prospective, and a high risk of bias and deviation from existing reporting standards are noted 126 .”
BackgroundUnsupervised word embeddings capture latent knowledge from materials science literature
Tshitoyan, V., Dagdelen, J., Weston, L., Dunn, A., Rong, Z., Kononova, O., Persson, K. A., Ceder, G., & Jain, A. (2019) · Nature · doi:10.1038/s41586-019-1335-8 · Cited by 1,123 · cited 1×
“In contrast, unsupervised learning, such as principal component analysis, k-means clustering and autoencoders, divides the clinical samples into different classes according to the features of the training data alone without corresponding labels 43 .”
MethodUnintended consequences of machine learning in medicine
Cabitza, F., Rasoini, R., & Gensini, G. F. (2017) · JAMA · doi:10.1001/jama.2017.7797 · Cited by 1,066
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Nishino, M., Ramaiya, N. H., Hatabu, H., & Hodi, F. S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.88 · Cited by 1,023
Artificial intelligence, bias and clinical safety
Challen, R., Denny, J., Pitt, M., Gompels, L., Edwards, T., & Tsaneva-Atanasova, K. (2019) · BMJ Quality & Safety · doi:10.1136/bmjqs-2018-008370 · Cited by 956 · cited 1×
“Fortunately, many researchers have proposed methods for visualization of DL features and prediction models, which could potentially decrease the black box perception 125 .”
MethodArlauckas, S. P., Garris, C. S., Kohler, R. H., Kitaoka, M., Cuccarese, M. F., Yang, K. S., Miller, M. A., Carlson, J. C., Freeman, G. J., Anthony, R. M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3604 · Cited by 669 · cited 1×
“Arlauckas et al. 97 found that tumor-associated macrophages quickly removed anti-PD-1 monoclonal antibodies from T cells, thereby impairing the cytotoxic T cell responses.”
BackgroundThere is a blind spot in AI research
Crawford, K., & Calo, R. (2016) · Nature · doi:10.1038/538311a · Cited by 580
Artificial Intelligence and Digital Pathology: Challenges and Opportunities
Tizhoosh, H. R., & Pantanowitz, L. (2018) · Journal of Pathology Informatics · doi:10.4103/jpi.jpi_53_18 · Cited by 544
Ethical governance is essential to building trust in robotics and artificial intelligence systems
Winfield, A. F. T., & Jirotka, M. (2018) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2018.0085 · Cited by 493
Kim, D. W., Jang, H. Y., Kim, K. W., Shin, Y., & Park, S. H. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2019.0025 · Cited by 459 · cited 1×
“Moreover, these algorithms could exploit data extracted from medical images that would not be obvious through human analysis that can be informative in regards to diagnosis, treatment sensitivity and prognosis 105 .”
BackgroundPD-1 Blockade in Tumors with Mismatch-Repair Deficiency
(2015) · New England Journal of Medicine · doi:10.1056/nejmc1510353 · Cited by 426
Deep Learning MR Imaging–based Attenuation Correction for PET/MR Imaging
Liu, F., Jang, H., Kijowski, R., Bradshaw, T., & McMillan, A. B. (2018) · Radiology · doi:10.1148/radiol.2017170700 · Cited by 412
Geis, J. R., Brady, A. P., Wu, C. C., Spencer, J., Ranschaert, E., Jaremko, J. L., Langer, S. G., Borondy Kitts, A., Birch, J., Shields, W. F., et al. (2019) · Radiology · doi:10.1148/radiol.2019191586 · Cited by 388
Machine Learning, Social Learning and the Governance of Self-Driving Cars
Stilgoe, J. (2017) · doi:10.2139/ssrn.2937316 · Cited by 376
Machine learning, social learning and the governance of self-driving cars
Stilgoe, J. (2018) · Social Studies of Science · doi:10.1177/0306312717741687 · Cited by 375 · cited 1×
“Third, we should understand the perspectives of the patient, practitioner and public in regards to the acceptability, benefits and risks of AI approaches in successful immunotherapy, as well as in establishing institutional and social mechanisms deserving acceptance and trust 141,142 .”
BackgroundDistributed deep learning networks among institutions for medical imaging
Chang, K., Balachandar, N., Lam, C., Yi, D., Brown, J., Beers, A., Rosen, B., Rubin, D. L., & Kalpathy-Cramer, J. (2018) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy017 · Cited by 340
Wallach, J. D., Boyack, K. W., & Ioannidis, J. P. A. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006930 · Cited by 269 · cited 1×
“Second, the reproducibility of AI is difficult to evaluate due to the limited availability of code and datasets, which might be solved by encouraging code and data sharing across scientific disciplines 127 e 129 .”
BackgroundEvaluating the impact of prediction models: lessons learned, challenges, and recommendations
Kappen, T. H., van Klei, W. A., van Wolfswinkel, L., Kalkman, C. J., Vergouwe, Y., & Moons, K. G. M. (2018) · Diagnostic and Prognostic Research · doi:10.1186/s41512-018-0033-6 · Cited by 215 · cited 1×
“Additionally, overpromising language is found in many articles despite obvious limitations in terms of design, transparency, reporting and risk of bias 126,130 .”
BackgroundProspects for combining immune checkpoint blockade with PARP inhibition
Li, A., Yi, M., Qin, S., Chu, Q., Luo, S., & Wu, K. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0784-8 · Cited by 143
Governing the safety of artificial intelligence in healthcare
Macrae, C. (2019) · BMJ Quality & Safety · doi:10.1136/bmjqs-2019-009484 · Cited by 123
Cited by
Lung cancer immunotherapy: progress, pitfalls, and promises
Lahiri, A., Maji, A., Potdar, P. D., Singh, N., Parikh, P., Bisht, B., Mukherjee, A., & Paul, M. K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01740-y · Cited by 1,102
Machine Learning for Lung Cancer Diagnosis, Treatment, and Prognosis
Li, Y., Wu, X., Yang, P., Jiang, G., & Luo, Y. (2022) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.11.003 · Cited by 263
The artificial intelligence and machine learning in lung cancer immunotherapy
Gao, Q., Yang, L., Lu, M., Jin, R., Ye, H., & Ma, T. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01456-y · Cited by 148
An in-depth review of AI-powered advancements in cancer drug discovery
Le, M. H. N., Nguyen, P. K., Nguyen, T. P. T., Nguyen, H. Q., Tam, D. N. H., Huynh, H. H., Huynh, P. K., & Le, N. Q. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167680 · Cited by 15
Machine Learning Applications in Lung Cancer Diagnosis, Treatment and Prognosis
Li, Y., Wu, X., Yang, P., Jiang, G., & Luo, Y. (2022) · arXiv · doi:10.48550/arxiv.2203.02794 · Cited by 2
Metadata
- Authors
- Xu, Z., Wang, X., Zeng, S., Ren, X., Yan, Y., & Gong, Z.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 11
- Issue
- 11
- Pages
- 3393-3405
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3128410443
- Cited by
- 126
- References
- 40
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.